Chester County News and Community Website
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced a significant milestone for its lead candidate, INO-3107, aimed at treating Recurrent Respiratory Papillomatosis (RRP). The European Medicines Agency’s Committee for …
INOVIO’s INO-3107 Receives European Certification for Quality and Data Compliance Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that its lead DNA medicine candidate, INO-3107, has been granted an Innovation Passport by the U.K.’s Innovative Licensing and Access Pathway (ILAP). …
INOVIO’s DNA Medicine INO-3107 Receives U.K. Innovation Passport Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has appointed Steven Egge as Chief Commercial Officer. Mr. Egge will spearhead the company’s commercial strategy and operations as it gears up for …
INOVIO Appoints Steven Egge as Chief Commercial Officer Amid Launch Preparations Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced this week the issuance of an equity grant to a newly hired employee under its 2022 Inducement Plan. The move aims to …
INOVIO Grants Equity Award to New Hire Under Inducement Plan Read More PLYMOUTH MEETING, PA — Biotechnology firm INOVIO (NASDAQ: INO) has been readded to the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes. This change …
INOVIO Rejoins Russell 2000 Index, Signals Progress in Biotech Advancements Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that President and CEO Dr. Jacqueline Shea and Chief Medical Officer Dr. Michael Sumner will participate in a virtual fireside chat. The …
INOVIO Executives to Discuss DNA Medicines in Upcoming Fireside Chat Read More PLYMOUTH MEETING, PA — Inovio Pharmaceuticals, Inc. (NASDAQ: INO) recently announced an equity grant to a newly hired employee under its 2022 Inducement Plan. The Compensation Committee of Inovio’s Board …
Inovio Pharmaceuticals Grants Equity to New Hire Under Inducement Plan Read More PLYMOUTH MEETING, PA — INOVIO Pharmaceuticals (NASDAQ: INO) has released its financial results for the first quarter of 2024, revealing significant developments in its drug pipeline and a strengthened balance …
INOVIO Reports First Quarter Financials, Prepares for Major Drug Submissions Read More PLYMOUTH MEETING, PA — INOVIO Pharmaceuticals Inc. (NASDAQ: INO) has announced the recent award of equity grants to two new employees as part of its 2022 Inducement Plan. The company’s …
INOVIO Awards Equity Grants to New Employees Under 2022 Inducement Plan Read More